Unlabelled: Atrial fibrillation is the most frequent form of cardiac arrhythmia. Its surgical management has improved in recent years with major advances in our knowledge of the underlying pathogenic mechanisms. This has led to simpler therapeutic strategies such as epicardial ablation. The aim of this comparative experimental study was to evaluate the efficacy of this treatment, achieved with either bipolar radiofrequency or cryoablation.
Materials And Methods: Twelve sheep were used. After left thoracotomy, epicardial ablation of the junction between the left pulmonary veins and the left atrium was achieved by means of bipolar radiofrequency in group A (n=6) and by cryoablation in group B (n=6). Electrical stimulation thresholds were determined before and after ablation. Four weeks after ablation, sheep were killed for pathologic studies.
Results: The mean stimulation threshold was 3.5+/-0.6 mA before ablation and 15.6+/-5.6 mA after ablation. The difference was significant in both groups, showing that effective conduction blockade was obtained with the two ablation methods. Histologic studies after radiofrequency and cryoablation showed limited coagulation necrosis and cellular rarefaction, respecting the supportive tissue.
Conclusions: Both methods of surgical ablation by the epicardial route yielded effective electrical isolation of the pulmonary vein junction with the left atrium. This conduction blockade was due to limited coagulation necrosis with myocyte rarefaction, of similar extents in the two procedures. Standardization and refinement of this technique could extend the treatment indications for atrial fibrillation associated with other cardiac disorders that require surgical treatment without opening the left atrium.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1016/j.acvd.2008.07.004 | DOI Listing |
Arq Bras Cardiol
January 2025
Serviço de Arritmia Cardíaca, Hospital SOS Cardio, Florianópolis, SC - Brasil.
Background: Treatment of atrial fibrillation (AF) with catheter ablation (CA) has evolved significantly. However, real-world data on long-term outcomes are limited, particularly in low- and middle-income countries.
Objective: This multicenter prospective cohort of consecutive patients aimed to evaluate the safety and efficacy of first-time CA for AF in Southern Brazil from 2009 to 2024.
Arq Bras Cardiol
January 2025
Cardiovascular Medicine Department, Faculty of Medicine, Tanta University, Tanta - Egito.
Background: There is still a significant population of patients with embolic stroke of Undetermined Source (ESUS) whose specific attributable cause of the stroke remains unknown.
Objectives: Our research aimed to assess clinical, electrocardiogram, laboratory, and echocardiographic parameters that may predict the propensity of paroxysmal atrial fibrillation (PAF).
Methods: We enrolled seventy-five ESUS patients who were in sinus rhythm at the time of stroke diagnosis to undergo in-hospital 7-day Holter monitoring, testing for Pro-BNP, and a standard echocardiographic examination.
PLoS One
January 2025
Department of Pharmacotherapy, University of Utah, Salt Lake City, Utah, United States of America.
Background: Venous thromboembolism (VTE) and atrial fibrillation (AF) disproportionately affect older adults, who are at increased risk of bleeding from treatment with anticoagulant therapy. The impact of bleeding on older adults' quality of life (QoL) is poorly understood due to the lack of a validated measure of their experience. This study's purpose is to describe the first evidence-based steps in developing a new condition-specific patient-reported outcome measure (PROM) for the effect of anticoagulant-related bleeding on older adults' QoL.
View Article and Find Full Text PDFPLoS One
January 2025
Department of Cardiovascular and Metabolic Medicine, Faculty of Health and Life Sciences, Institute of Life Course and Medical Sciences, University of Liverpool, Liverpool, United Kingdom.
Introduction: New Onset Atrial Fibrillation (NOAF) is the most common arrhythmia in intensive care. Complications of NOAF include thromboembolic events such as myocardial infarction and stroke, which contribute to a greater risk of mortality. Inflammatory and coagulation biomarkers in sepsis are thought to be associated with NOAF development.
View Article and Find Full Text PDFEur Heart J
January 2025
Department of Cardiology, University of Groningen, University Medical Center Groningen, P.O. Box 30.001, 9700 RB Groningen, The Netherlands.
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!